found
butanol
fraction
cinnamomi
cortex
show
moder
inhibitori
activ
wildtyp
sever
acut
respiratori
syndrom
coronaviru
wtsarscov
hivsarscov
pseudoviru
infect
inhibit
pseudoviru
also
seen
cell
pretreat
cc
ic
gml
respect
howev
highest
activ
wtsarscov
observ
virus
treat
extract
challeng
ic
gml
si
respect
among
compound
fraction
cc
procyanidin
procyanidin
show
moder
antiwtsarscov
activ
ic
si
respect
also
sought
determin
whether
could
interfer
clathrindepend
endocytosi
pathway
use
transferrin
receptor
tfr
indic
inhibit
intern
tfr
procyanidin
taken
togeth
contain
unknown
substanc
could
inhibit
infect
probabl
interf
endocytosi
also
contain
procyanidin
inhibit
intern
inhibit
infect
therefor
cc
extract
contain
antiviru
activ
act
distinct
mechan
accord
differ
compound
mixtur
sever
acut
respiratori
syndrom
sar
atyp
type
contagi
pneumonia
high
mortal
rate
caus
sar
coronaviru
sarscov
drosten
et
al
ksiazek
et
al
infect
patient
die
juli
lingappa
et
al
interferon
haagman
et
al
paraga
et
al
tan
et
al
barnard
et
al
glycyrrhizin
sarscov
sever
acut
respiratori
syndrom
coronaviru
hiv
human
immunodefici
viru
vsv
vesicular
stomat
viru
wildtyp
sarscov
wtsarscov
angiotensin
convert
enzym
inhibitori
concentr
growth
reduct
cell
si
select
index
tissu
cultur
infecti
dose
pb
phosphatebuff
salin
bsa
bovin
serum
albumin
dmem
dulbecco
modifi
eagl
medium
fitc
fluorescein
isothiocyan
pe
phycoerythrin
chx
cycloheximid
mfi
mean
fluoresc
intens
glucos
tgg
luteolin
yi
et
al
lycori
radiat
sy
emodin
ho
et
al
barnard
et
al
proteas
inhibitor
report
anti
sarscov
activ
vitro
howev
select
indic
materi
high
mechan
action
clear
de
clercq
therefor
research
necessari
discov
drug
studi
mechan
practic
interfer
sarscov
infect
report
medicin
herb
combin
western
medicin
improv
symptom
decreas
requir
dosag
corticosteroid
sar
patient
liu
et
al
identifi
potenti
inhibitor
sarscov
screen
seven
differ
medicin
herb
report
use
sar
patient
also
fraction
extract
character
inhibitori
molecul
spike
protein
surfac
sarscov
particl
mediat
bind
viru
cell
surfac
receptor
angiotensin
convert
enzym
simmon
et
al
li
et
al
use
pseudoviru
consist
luciferas
encod
human
immunodefici
viru
hiv
yang
et
al
sarscov
protein
screen
inhibitor
pseudotyp
viru
replic
luciferas
activ
specif
see
front
matter
elsevi
bv
right
reserv
reflect
singleround
infect
inhibitori
activ
shown
pseudotyp
viru
assay
also
confirm
wildtyp
sarscov
wtsarscov
infect
assay
use
sarscov
genbank
access
bj
whether
envelop
nonenvelop
mani
virus
depend
host
cell
endocyt
pathway
entri
sarscov
glycoprotein
mediat
viral
entri
phdepend
endocytosi
like
vesicular
stomat
viru
vsv
sun
et
al
endocyt
pathway
taken
virus
divid
clathrinmedi
clathrinindepend
pathway
marsh
heleniu
recent
demonstr
sarscov
mainli
util
clathrinmedi
endocytosi
pathway
entri
target
cell
inou
et
al
therefor
examin
whether
effect
herb
purifi
compound
may
affect
endocytot
pathway
follow
cell
line
obtain
cell
resourc
center
biomed
research
institut
develop
age
cancer
tohoku
univers
jurkat
cell
cell
cultur
either
dulbecco
modifi
eagl
medium
dmem
medium
supplement
fetal
bovin
serum
uml
penicillin
gml
streptomycin
antibiot
water
extract
prepar
kind
dri
medicin
herb
four
fraction
sampl
cinnamomi
cortex
cc
caryophylli
flo
cf
provid
tsumura
co
tokyo
japan
dri
medicin
herb
includ
forsythia
fructu
scutellaria
radix
astragali
radix
bupleuri
radix
glycyrrhiza
radix
cc
cf
dri
medicin
herb
kg
boil
reflux
l
distil
water
h
aqueou
extract
separ
residu
centrifug
follow
concentr
reduc
pressur
concentr
extract
lyophil
four
fraction
cc
obtain
method
shown
fig
cc
g
extract
ml
aqueou
ethanol
aq
etohh
reflux
h
obtain
extract
concentr
reduc
pressur
yield
aq
etohh
extract
g
fraction
g
could
dissolv
distil
water
extract
ethylac
etat
acoet
ml
nbutanol
nbuoh
ml
nbuoh
layer
aq
layer
acoet
layer
concentr
reduc
pressur
success
yield
fraction
g
g
g
respect
four
fraction
cf
also
obtain
essenti
similar
method
describ
fraction
suspend
dimethyl
sulfoxid
dmso
concentr
mgml
serial
dilut
dmem
phenethi
alcohol
hydroxyacetophenon
ohydroxyacetophenon
isoeugenol
acid
acid
acid
ferul
acid
pcymen
ethylcinnam
cinnamylacet
purchas
wako
osaka
japan
transcinnamaldehyd
transcinnam
acid
licochalconea
cinnamaldehyd
cycloheximid
chx
purchas
sigma
st
loui
mo
eight
compound
procyanidin
procyanidin
procyanidin
procyanidin
procyanidin
oligom
epicatechin
catechin
cinnamtannin
purifi
cc
describ
previous
nonaka
et
al
chemic
dissolv
dmso
mgml
mm
pseudotyp
lentivirus
prepar
describ
previous
yang
et
al
cell
cotransfect
lentivir
dna
plasmid
encod
fulllength
sarss
gj
nabel
nation
institut
health
bethesda
md
vsvg
naldini
et
al
gag
antigen
level
measur
use
antigen
assay
kit
zeptometrix
corpor
new
york
five
ng
gener
hivsarscov
hivvsvg
infect
cell
cellswel
plate
h
cultiv
cell
wash
twice
dmem
replac
complet
medium
fortyeight
hour
infect
luciferas
activ
measur
mithra
berthold
technolog
gmbh
co
kg
germani
accord
manufactur
instruct
supernat
contain
ng
hivsarscov
hivvsvg
pseudovirus
mix
without
reagent
differ
concentr
ad
cell
dmso
solvent
also
use
control
h
infect
cell
wash
twice
dmem
replac
complet
medium
without
reagent
rel
luciferas
activ
calcul
percentag
control
culturebackground
inhibit
concentr
ic
reagent
determin
curv
relat
luciferas
activ
concentr
reagent
evalu
step
viru
replic
inhibit
reagent
examin
effect
addit
studi
reagent
ad
cell
h
hivsarscov
infect
h
requir
obtain
stabl
luciferas
activ
yang
et
al
furthermor
cell
pretreat
variou
concentr
reagent
h
follow
wash
twice
challeng
pseudoviru
determin
whether
reagent
work
cell
virus
wtsarscov
strain
genbank
access
use
assay
perform
plaqu
reduct
assay
time
cell
cultur
infect
dose
ccid
wtsarscov
ad
l
reagent
min
c
transfer
onto
plate
cellswel
cell
dmso
solvent
also
use
control
h
infect
cell
wash
twice
dmem
agaros
ad
onto
cell
surfac
secondari
agaros
layer
neutral
red
dye
ad
third
day
incub
number
plaqu
count
ad
neutral
red
dye
inhibitori
concentr
plaqu
reduct
ic
determin
curv
relat
plaqu
number
concentr
reagent
experi
chose
optim
concentr
reagent
yield
cell
viabil
cytotox
analysi
reagent
perform
use
cell
count
dojindo
laboratori
kumamoto
japan
condit
describ
pseudoviru
infect
extract
incub
cell
h
viabil
determin
use
cell
titer
aqueou
nonradioact
cell
prolifer
assay
kit
promega
growth
reduct
cc
calcul
viabil
jurkat
cell
determin
trypan
blue
dye
exclus
method
select
index
calcul
cc
ic
describ
elsewher
baba
et
al
investig
whether
compound
affect
express
surfac
cell
cell
either
left
untreat
pretreat
cce
cfe
mgml
three
compound
procyanidin
procyanidin
cinnamtannin
c
min
dmso
solvent
also
use
control
wash
pb
cell
detach
treatment
mm
edta
min
detach
cell
react
biotinyl
antihuman
ectodomain
antibodi
r
system
reaction
phycoerythrin
pe
streptavidin
bd
pharmingen
cell
wash
subject
flow
cytometri
analysi
tfr
stain
jurkat
cell
cell
use
assay
jurkat
cell
incub
extract
differ
concentr
without
gml
cycloheximid
gml
extract
variou
period
min
c
follow
wash
twice
cold
pb
contain
bsa
ten
l
peantitfr
bd
bioscienc
l
bd
bioscienc
incub
cell
min
c
wash
cell
analyz
cytom
beckman
coulter
fullerton
ca
data
analyz
use
cxp
analysi
softwar
version
cell
cultur
plate
one
day
treatment
extract
ad
min
cell
wash
twice
pb
detach
treatment
mm
edta
min
recov
cell
react
peantitfr
bd
bioscienc
bd
bioscienc
wash
cell
analyz
cytom
beckman
coulter
fullerton
ca
order
observ
intern
transferrin
jurkat
cell
wash
twice
cold
pb
cell
incub
l
pb
contain
differ
concentr
extract
ice
min
polystyren
roundbottom
tube
falcon
transferrin
molecular
probe
ad
final
concentr
gml
incub
anoth
min
ice
treat
cell
wash
twice
cold
pb
resuspend
cellsml
cold
pb
presenc
absenc
variou
concentr
extract
incub
c
min
crotzer
et
al
intern
stop
incub
cell
ice
ad
cold
pb
cell
fix
paraformaldehyd
plate
polyllysinetr
cover
slip
sigmaaldrich
cell
view
use
zeiss
microscop
singl
section
middl
cell
shown
first
screen
extract
medicin
herb
hivsarscov
pseudoviru
infect
two
cce
cinnamomi
cortex
extract
cfe
caryophylli
flo
extract
appar
show
low
ic
gml
slight
moder
si
hivsarscov
pseudoviru
tabl
inhibitori
activ
dosedepend
fig
note
cce
cfe
also
inhibit
infect
hivvsvg
pseudoviru
fig
character
respons
substanc
separ
four
fraction
cc
cf
use
aqueou
ethanol
ethylacet
nbutanol
extract
experi
repeat
three
time
averag
inhibitori
concentr
extract
inhibit
luciferas
activ
control
valu
cytotox
concentr
extract
reduc
cell
viabil
shown
select
index
si
correspond
method
fig
ic
lowest
among
four
fraction
cc
although
fraction
show
slight
inhibitori
activ
tabl
dosedepend
inhibit
also
confirm
use
hivsarscov
hivvsvg
pseudoviru
infect
fig
b
case
cf
fraction
show
moder
inhibitori
activ
tabl
pseudovirus
replic
infect
cell
singl
cycl
manner
luciferas
activ
sole
depend
entri
also
transcript
protein
synthesi
therefor
inhibitori
activ
cce
cfe
also
examin
differ
time
ad
cultur
h
infect
h
infect
hivsarscov
result
show
inhibit
occur
former
case
data
shown
suggest
inhibit
hivsarscov
infect
earli
step
viru
replic
furthermor
pretreat
cell
cce
show
appar
inhibitori
examin
inhibitori
effect
select
extract
cce
cfe
use
quantit
assay
plaqu
reduct
assay
infect
wtsarscov
assay
cce
inhibit
wtsarscov
infect
virus
mix
herb
ad
onto
target
cell
cfe
show
weak
inhibitori
activ
tabl
ic
count
plaqu
number
wtsarscov
pretreat
h
cce
compound
procyanidin
procyanidin
cinnamtannin
differ
virus
ad
simultan
drug
h
p
therefor
could
prove
virucid
effect
compound
analyz
inhibitori
activ
ad
mixtur
compound
viru
h
target
cell
among
four
fraction
cc
show
moder
inhibitori
activ
plaqu
reduct
assay
suggest
contain
biolog
activ
substanc
tabl
unexpectedli
four
fraction
cf
well
cfe
inhibit
wtsarscov
infect
tabl
cce
may
contain
specif
compound
inhibit
viru
infect
clathrindepend
endocytosi
tri
identifi
compound
sever
compound
report
present
experi
repeat
three
time
averag
inhibitori
concentr
extract
inhibit
luciferas
activ
control
valu
cytotox
concentr
extract
reduc
cell
viabil
shown
si
correspond
cc
deriv
also
studi
heid
nonaka
et
al
among
chemic
transcinnam
acid
phenethi
alcohol
acid
show
slight
suppress
effect
select
index
si
hivsarscov
pseudoviru
infect
tabl
howev
chemic
show
antisarscov
activ
wtsarscov
infect
even
highest
optim
concentr
data
shown
case
eight
compound
fraction
cc
examin
pseudoviru
wtsarscov
infect
among
compound
procyanidin
procyanidin
cinnamtannin
show
slight
moder
inhibitori
effect
assay
tabl
cell
treat
cce
cfe
mgml
three
compound
procyanidin
procyanidin
cinnamtannin
c
min
use
flow
cytometri
analysi
posit
percentag
mfi
analyz
signific
differ
paramet
treat
cell
untreat
control
percentag
mfi
nontreat
cell
treat
cell
respect
cce
cfe
inhibit
sarscov
infect
also
hivvsvg
suspect
may
act
share
endocyt
pathway
virus
virus
known
enter
cell
via
clathrindepend
endocyt
pathway
sun
et
al
inou
et
al
tfr
consid
marker
clathrinmedi
endocytosi
marker
clathrinindepend
endocytosi
mellman
naslavski
et
al
expect
cce
upregul
tfr
express
jurkat
cell
doseand
timedepend
manner
fig
c
furthermor
neither
fig
cfe
fraction
data
shown
influenc
tfr
express
enhanc
express
tfr
jurkat
cell
could
explain
enhanc
protein
synthesi
regul
also
observ
cell
incub
chx
upregul
tfr
seen
jurkat
cell
incub
cce
c
upregul
tfr
also
found
treat
cell
cce
mfi
untreat
cell
cce
respect
case
eight
compound
fraction
cc
examin
pseudoviru
wtsarscov
infect
procyanidin
procyanidin
cinnamtannin
show
inhibitori
effect
sar
viru
infect
tabl
effect
express
tfr
jurkat
cell
examin
flow
cytometr
analysi
show
procyanidin
cinnamtannin
upregul
express
tfr
doseand
timedepend
manner
fig
procyanidin
affect
express
tfr
even
though
inhibit
infect
wtsarscov
si
tfr
recycl
molecul
cell
consid
interfer
cce
recycl
tfr
result
enhanc
express
tfr
jurkat
cell
use
detect
intern
step
endocytosi
c
incub
intern
jurkat
cell
absenc
herb
min
fig
middl
panel
examin
whether
extract
interf
intern
jurkat
cell
cce
fraction
except
block
intern
gml
tabl
intern
observ
ad
rel
low
concentr
gml
close
ic
wildtyp
infect
gml
cfe
tabl
intern
jurkat
cell
treatment
extract
intern
gml
gml
gml
fraction
effect
intern
tabl
even
concentr
gml
higher
ic
hivsarscov
pseudoviru
infect
tabl
final
procyanidin
inhibit
intern
optim
concentr
use
pseudoviru
evalu
antisarscov
activ
medicin
herb
use
luciferas
report
kind
medicin
herb
recommend
use
sar
patient
liu
et
al
examin
effect
hivsarscov
pseudoviru
infect
two
herbal
extract
cce
cfe
show
slightli
moder
inhibitori
activ
hivsarscov
hivvsvg
pseudoviru
infect
evalu
antiviru
activ
fraction
extract
found
four
fraction
cf
show
slightli
moder
inhibitori
activ
pseudoviru
infect
assay
tabl
hivbas
pseudoviru
rna
revers
transcrib
follow
integr
make
report
gene
product
examin
whether
inhibitor
could
inhibit
wildtyp
infect
plaqu
reduct
assay
wtsarscov
infect
si
found
moder
howev
cfe
fraction
show
signific
inhibitori
activ
believ
cce
may
inhibit
earli
step
sarscov
infect
base
time
addit
studi
plaqu
reduct
assay
wildtyp
infect
furthermor
extract
appear
act
cell
viru
inhibit
infect
cell
pretreat
cell
virus
ic
gml
cce
gml
pretreat
cell
much
higher
obtain
experi
reagent
mix
viru
first
ic
gml
cce
gml
although
could
demonstr
virucid
activ
assay
howev
mechan
inhibitori
activ
pretreat
studi
cce
inhibit
sarscov
also
hivvsvg
pseudoviru
infect
suspect
might
interact
molecul
import
entri
virus
known
vsv
mani
envelop
virus
must
endocytos
infect
transport
earli
endosom
late
endosom
lysosom
use
endocyt
pathway
vsv
wellknown
infect
cell
phdepend
manner
shown
util
clathrinmedi
endocyt
pathway
upon
infect
also
report
sarscov
entri
clathrindepend
therefor
examin
whether
cce
cfe
could
interfer
recycl
tfr
expect
cce
cfe
upregul
tfr
express
timeand
dosedepend
manner
despit
presenc
chx
fig
tfrinduc
activ
higher
cce
result
suggest
antiviru
activ
cfe
might
relat
endocyt
pathway
virus
tfr
wellknown
clathrinmedi
recycl
molecul
interfer
recycl
may
enhanc
tfr
express
cell
surfac
therefor
hypothes
may
biolog
activ
via
effect
clathrin
pathway
fact
inhibit
intern
tfr
rel
low
concentr
gml
tabl
wellknown
cc
contain
larg
amount
proanthocyanidin
prior
gu
also
known
condens
tannin
accredit
varieti
benefici
effect
health
beecher
tannin
relat
compound
report
possess
antihiv
activ
lee
et
al
hx
xu
et
al
proantocyanidin
report
antihiv
antihsv
activ
de
bruyn
et
al
therefor
examin
compound
isol
cc
variou
biolog
activ
found
three
compound
structur
similar
show
inhibitori
activ
sarscov
infect
fig
two
caus
upregul
tfr
express
structur
procyanidin
close
relat
except
configur
posit
procyanidin
inhibit
sarscov
infect
upregul
tfr
express
data
shown
data
strongli
suggest
antisarscov
activ
could
explain
procyanidin
fact
procyanidin
detect
tanaka
unpublish
observ
march
howev
none
procyanidin
inhibit
intern
tfr
optim
concentr
data
shown
suggest
may
act
tfr
recycl
pathway
directli
also
demonstr
compound
affect
express
sarscov
receptor
previou
studi
indic
procyanidin
highest
si
hiv
suggest
virucid
effect
de
bruyn
et
al
therefor
possibl
may
contain
endocytosi
inhibitor
procyanidin
although
could
identifi
substanc
could
inhibit
endocytosi
upregul
tfr
procyanidin
puzzl
phenomenon
discov
experi
known
proanthocyanidin
relat
compound
chelat
activ
scalbert
et
al
deplet
fe
cell
medium
caus
upregul
tfr
transcript
howev
upregul
mrna
observ
h
chelat
ad
xu
et
al
iron
chelat
clinic
relev
anthracyclin
caus
alter
express
ironregul
gene
atyp
chang
intracellular
iron
distribut
traffick
xu
et
al
could
see
upregul
within
min
addit
procyanidin
fig
also
known
transferrin
princip
plasma
protein
bind
wine
catechin
brunet
et
al
therefor
swift
upregul
tfr
may
caus
deplet
tfn
medium
note
induc
deplet
intracellular
iron
content
upregul
function
tfr
human
epidermoid
cancer
kb
cell
caraglia
et
al
also
antisar
activ
paraga
et
al
tan
et
al
barnard
et
al
although
relationship
two
activ
clear
higher
si
procyanidin
could
explain
upregul
tfr
studi
found
contain
inhibitor
sar
viru
infect
fraction
also
inhibit
intern
tfr
indic
interfer
clathrindepend
endocytosi
fraction
also
contain
procyanidin
could
virucid
effect
show
upregul
tfr
probabl
deplet
transferrin
andor
iron
cultur
novel
complex
biolog
activ
cc
could
lead
amelior
symptom
number
virusinfect
diseas
includ
sar
